Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

Xue 2019 Sci Rep

From Bioblast
Publications in the MiPMap
Xue YP, Kao MC, Lan CY (2019) Novel mitochondrial complex I-inhibiting peptides restrain NADH dehydrogenase activity. Sci Rep 9:13694.

Β» PMID: 31548559 Open Access

Xue YP, Kao MC, Lan CY (2019) Sci Rep

Abstract: The emergence of drug-resistant fungal pathogens is becoming increasingly serious due to overuse of antifungals. Antimicrobial peptides have potent activity against a broad spectrum of pathogens, including fungi, and are considered a potential new class of antifungals. In this study, we examined the activities of the newly designed peptides P-113Du and P-113Tri, together with their parental peptide P-113, against the human fungal pathogen Candida albicans. The results showed that these peptides inhibit mitochondrial complex I, specifically NADH dehydrogenase, of the electron transport chain. Moreover, P-113Du and P-113Tri also block alternative NADH dehydrogenases. Currently, most inhibitors of the mitochondrial complex I are small molecules or artificially-designed antibodies. Here, we demonstrated novel functions of antimicrobial peptides in inhibiting the mitochondrial complex I of C. albicans, providing insight in the development of new antifungal agents.

β€’ Bioblast editor: Plangger M


Labels: MiParea: Respiration, Pharmacology;toxicology 


Organism: Fungi 

Preparation: Intact cells  Enzyme: Complex I 


HRR: Oxygraph-2k 

Labels, 2019-10